Garza AAG, Rodríguez BR, López EJA, Rivera PC, Navarro VJL

Idioma: Español
Referencias bibliográficas: 34
Paginas: 100-104
Archivo PDF: 146.10 Kb.

RESUMEN

El Síndrome de choque tóxico estreptocócico (SCTE) es debido a exotoxinas pirogénicas del estreptococo del grupo A (EGA). Se asocia a infecciones de la piel, tejidos blandos, e inclusive puede presentarse posterior a infecciones de las vías aéreas superiores. Su cuadro clínico es inespecífico y rápidamente progresivo. Hay asociación de embolismo pulmonar séptico con la flebitis supurativa, presencia de hipotensión, inmovilidad, colocación de catéteres femorales, entre otras cosas. Sin embargo, en la literatura hay poca información en donde se asocie SCTE y trombosis intracardiaca. Presentamos el caso de una paciente preescolar de 5 años de edad con SCTE, la cual falleció por un trombo intracardiaco.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Stevens DL. The flesh-eating bacterium: what’s next? J Infect Dis 1999; 179(2): S366-74.

2. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995; 1: 69-78.

3. Drage LA. Life-threatening rashes: dermatological sigris of four infectious diseases. Mayo Clin Proc 1999; 74: 68-72.

4. Wolf JE., Rabinowitz L.G. Streptococcal toxic shock-like syndrome. Arch Dermatol 1995; 131: 73-7.

5. Davies HD, Matlow A, Sariver SR. Apparcrit lower rates Ustreptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J 1994; 13: 49-56.

6. Hauser A.R. Another toxic shock syndrome. Streptococcal infection is even more dangerous than the staphylococcal form. Postgrad Med 1998; 104: 31-443-4.

7. Norrby SR. Norrby-Teglund A. Infections due to group A Streptococcus, new concepts and potential treatment strategies. Ann Acad Med Singapore 1997; 26: 691-3.

8. Krause R. Microbial factors in disease emergence illustrated by streptococcal toxic shock syndrome. FEMS Imm Med Microbiol 1997; 18: 227-32.

9. A household cluster of fulminate group A Streptococcus pneumonia associated with toxic shock syndrome-Quebec. Can Commun Dis Rep 1996; 22: 41-3.

10. Ahmed S, Avoub EM. Severe, invasive group A streptococcal disease and toxic shock. Pediatr Ann May 1998; 27(5): 287-92.

11. Perez CM, Kubak BM, Cryer HG. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin. Am J. Med 1997; 102: 111-3.

12. Lobe TE. Neonatal shock. Curr Opin Pediatr 1994; 6: 348-52.

13. Navazesh M, Mulligan R, Sobel S. Toxic shock and Domain syndromes in a dental patient. Spec Care Dentist 1994; 14: 246-51.

14. Bemaldo de Quiros JC, Moreno S, Cercenado E. Group A streptococcal bacteremia, A 10-year prospective study. Medicine 1997; 76: 238-48.

15. Anand Kurnar, Cameron Haery, Joseph E Parrillo. Myocardial dysfunction in septic shock. Critical Care Clin 2000; 16: 140-3.

16. Jason Bannan, Kurnar Visvanathan, John B. Zabriskie. Structure and function of streptococcal and staphylococcal superantigens in septic shock. Infec Dis Clin North Am 1999; 13: 387-96.

17. Kevin B, Laupland H. Dele Davies; Donald E. Low. Invasive group a streptococcal. Disease in Children and Association With Varicella-Zoster Virus Infection. Pediatrics 2000; 105: 160-69.

18. Bergmann JF, Elkharrat D. Prevention of venous thromboembolic risk in non-surgical patients. Haemostasis 1996; 26(2): 16-23.

19. Sutor AH. Uhl M.Diagnosis of thromboembolic disease during infancy and childhood. Semin Thromb Hemost 1997; 23: 237-46.

20. Mark C. Rogers. Pediatric Intensive Care Textbook. third ed, 1996.

21. Garg RK, Gheorghiade m, Jafri SM. Antiplatelet and anticoagulant therapy in the prevention of thromboembolic in chronic heart failure. Progr Cardio Dis 1998; 41: 225-36.

22. Waller BF, Rohr TM, McLaugh1in T. Intracardiac thrombi: frequency, location, aetiology, and complication: a morphologic review-Part V. Clin Cardiol 1995; 18: 731-4.

23. Thompson CA, Skelton TN. Thromboembolism in the right side of the heart. South Med Journal 1999; 92(8): 826-30.

24. Lip GY. Intracardiac thrombus fonnation in cardiac impairment: the role of anticoagulant therapy. Postgrad Med Journal Dec 1996; 72(854): 731-8.

25. Neal A Halsey, Georges Peter. Red Book, Enfermedades Infecciosas en Pediatría 24 Edición, Agosto 1999; 3: 229-241.

26. Gonzalez Ruiz A, Ridgway GL, Cohen SL. Varicella gangrenous with toxic shock-like syndrome due to group A Streptococcus infection in adult. Clin Infect Dis 1995; 20: 1058-1060.

27. Mazrou AM. Streptococcal. toxic shock-like syndrome: case report and review of the literature. Ann Trop Paediatr 1994; 14: 145-8.

28. Gardam MA, Low DE, Saginur R. Group B streptococcal fasciitis and streptococcal toxic shock-like syndrome in adults. Arch Intern Medic 1998; 158: 1704-8.

29. Kouwabumpat D. Varicella complicated by group A streptococcal sepsis and osteonecrosis. Pediatrics 1999; 104: 211-15.

30. Nields H. Streptococcal toxic shock syndrome presenting as suspected child abuse. Am J Foren Med Pathol 1998; 19: 93-7.

31. Laupland EB. Invasive group A streptococcal disease in the Netherlands; evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis 2000; 181: 631-8.

32. Eriksson BK. Invasive group A streptococcal infections; T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 1995; 180: 410-8.

33. Eriksson BK. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic syndrome. Clin Infect Dis 1998; 27: 428-36.

34. Zurawski CA. Invasive disease due to group A beta haemolytic streptococci continued occurrence in children in North Carolina. South Med J 1998; 91: 333-7.